A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
S628 survival (LPFS) rate was 75.8% at median follow-up of 19 months, and 1-and 2-year LPFS was 93.8%, 73.2% respectively. Overall survival was relatively worse, 90.8% at 1 year and 51.9% at 2 year, because most of patients had a medical problem in lung or heart. While all patients developed grade 1 radiation pneumonitis within 3 months of SRS treatment, none developed symptomatic or serious late complications. Conclusions: The results demonstrate that fractionated SRS on consecutive days wasdoi:10.1097/01.jto.0000283807.63177.8f fatcat:zarxdinucvdd5gwwoviovnqtnq